Medically reviewed by Jeffrey S. Lander, MDMedically reviewed by Jeffrey S. Lander, MD In the vast majority of patients with ...

Stable Angina Management Market. The global stable angina management market is on a robust growth trajectory, expected to ...

Objective: To assess the clinical efficacy, safety and effects on quality of life of trimetazidine modified release (MR) in patients with stable angina. Methods: This large, open-label ...

A former doctor has claimed that people should look out for three subtle symptoms of having the same heart problem that ...

Jeremy Clarkson’s apprehension that something might be seriously amiss was well-founded. The combination of “clamminess”, ...

A former doctor has claimed that people could be suffering form the same heart condition that Jeremy Clarkson had if they ...

In January 2006, the U.S. Food and Drug Administration (FDA) approved a new antianginal agent for the treatment of chronic stable angina, ranolazine (Ranexa™; CV Therapeutics, Inc.). The drug ...

Patient self-management plans:- What is the clinical and cost effectiveness of a self-management plan for people with stable angina? Why this is important:- Stable angina is a chronic condition.

However, there is no evidence to suggest that cardiac rehabilitation is clinically or cost effective for managing stable angina. Research to date has looked at short-term outcomes, such as a change in ...